Thermo Fisher Scientific Inc (
) will begin trading ex-dividend on March 13, 2013. A cash dividend
payment of $0.15 per share is scheduled to be paid on April 15,
2013. Shareholders who purchased TMO stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
15.38% increase over the same period a year ago.
The previous trading day's last sale of TMO was $77.04,
representing a -0.09% decrease from the 52 week high of $77.11 and
a 60.03% increase over the 52 week low of $48.14.
TMO is a part of the Capital Goods sector, which includes
companies such as Danaher Corporation (
) and Canon, Inc. (
). TMO's current earnings per share, an indicator of a company's
profitability, is $3.21. Zacks Investment Research reports TMO's
forecasted earnings growth in 2013 as 9.7%, compared to an industry
average of -3.6%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to TMO through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TMO as a top-10 holding:
- iShares Dow Jones U.S. Medical Devices Index Fund (
- PowerShares Dynamic Heathcare (
- First Trust Value Line Equity Allocation Index(sm)Fund (
- First Trust Large Cap Growth AlphaDEX Fund (based on the
- First Trust MuFirst Trust Multi CG AlphaDEX (
The top-performing ETF of this group is FVI with an increase of
14.78% over the last 100 days. IHI has the highest percent
weighting of TMO at 8.07%.